HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kim Papp Selected Research

bleselumab

5/2018Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate-to-severe plaque psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kim Papp Research Topics

Disease

72Psoriasis (Pustulosis Palmaris et Plantaris)
06/2022 - 09/2004
16Atopic Dermatitis (Atopic Eczema)
06/2022 - 07/2002
14Psoriatic Arthritis
07/2022 - 04/2009
13Infections
01/2022 - 07/2002
4Nasopharyngitis
01/2022 - 04/2011
4Neoplasms (Cancer)
02/2020 - 12/2005
3Chronic Disease (Chronic Diseases)
07/2022 - 01/2006
3Respiratory Tract Infections (Respiratory Tract Infection)
06/2022 - 11/2016
3Headache (Headaches)
06/2022 - 07/2010
3Acne Vulgaris
06/2022 - 02/2008
3Inflammation (Inflammations)
10/2020 - 08/2012
3Pruritus (Itching)
09/2020 - 08/2002
2Fatigue
07/2022 - 01/2006
2Nausea
06/2022 - 01/2022
2Body Weight (Weight, Body)
01/2022 - 10/2015
2Eczema
07/2021 - 07/2002
2Ulcerative Colitis
01/2021 - 02/2020
2Rheumatoid Arthritis
01/2021 - 01/2017
2Skin Neoplasms (Skin Cancer)
02/2020 - 07/2015
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2020 - 01/2018
2Ankylosing Spondylitis
03/2019 - 04/2009
2Candidiasis (Moniliasis)
01/2018 - 10/2015
2Myocardial Infarction
10/2017 - 03/2010
2Hypertension (High Blood Pressure)
01/2017 - 07/2012
2Necrosis
01/2013 - 10/2005
1Pain (Aches)
07/2022
1Herpes Simplex
06/2022
1Herpes Zoster
06/2022
1Diarrhea
01/2022
1Celiac Disease (Celiac Sprue)
01/2022
1Urticaria (Hives)
07/2020
1Chronic Urticaria
07/2020
1Crohn Disease (Crohn's Disease)
02/2020
1Melanoma (Melanoma, Malignant)
10/2018

Drug/Important Bio-Agent (IBA)

13Monoclonal AntibodiesIBA
01/2022 - 10/2005
11Biological ProductsIBA
11/2020 - 09/2004
10CytokinesIBA
06/2020 - 07/2002
8Interleukin-17 (Interleukin 17)IBA
01/2022 - 07/2014
8InterleukinsIBA
03/2019 - 12/2008
8Adalimumab (Humira)FDA Link
01/2018 - 01/2008
7ixekizumabIBA
03/2022 - 01/2015
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 10/2005
6brodalumabIBA
11/2020 - 12/2014
5apremilastIBA
01/2022 - 08/2012
5Ointments (Pastes)IBA
01/2020 - 09/2010
5Pharmaceutical PreparationsIBA
10/2018 - 08/2002
4calcipotriene (calcipotriol)FDA LinkGeneric
06/2022 - 09/2010
4Ustekinumab (CNTO 1275)FDA Link
10/2015 - 12/2008
4Etanercept (Enbrel)FDA Link
08/2015 - 01/2006
4Infliximab (Remicade)FDA Link
07/2015 - 10/2005
4Clobetasol (Clobetasol Propionate)FDA LinkGeneric
10/2011 - 01/2010
4Alefacept (Amevive)FDA Link
12/2009 - 12/2005
4efalizumab (Raptiva)FDA Link
11/2008 - 12/2005
3risankizumabIBA
07/2022 - 01/2022
3Janus Kinase InhibitorsIBA
06/2022 - 06/2020
3ruxolitinibIBA
10/2021 - 01/2020
3omega-Chloroacetophenone (Mace)IBA
02/2020 - 07/2015
3Phosphodiesterase 4 InhibitorsIBA
01/2020 - 07/2015
3dupilumabIBA
09/2018 - 01/2016
3SteroidsIBA
01/2018 - 07/2011
3Interleukin-12 (IL 12)IBA
01/2018 - 12/2008
3Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
07/2015 - 08/2012
3golimumabFDA Link
01/2013 - 04/2009
3pimecrolimus (Elidel)FDA Link
12/2004 - 07/2002
2AerosolsIBA
06/2022 - 01/2016
2betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
06/2022 - 01/2011
2baricitinibIBA
01/2022 - 07/2021
2Interleukin-23 (Interleukin 23)IBA
01/2022 - 01/2022
2abrocitinibIBA
10/2020 - 09/2020
2Interleukin-13IBA
03/2018 - 01/2016
2secukinumabIBA
01/2015 - 07/2014
2Calcineurin InhibitorsIBA
11/2011 - 03/2006
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2011 - 10/2011
2Vitamin DFDA LinkGeneric
11/2011 - 10/2011
2Calcitriol (Calcijex)FDA LinkGeneric
10/2011 - 07/2011
2siplizumabIBA
07/2010 - 07/2009
1Creatine Kinase (Creatine Phosphokinase)IBA
06/2022
1Janus KinasesIBA
06/2022
1Antirheumatic Agents (DMARD)IBA
01/2022
1Glutens (Glutelin)IBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1AntipruriticsIBA
10/2021
1Janus Kinase 2IBA
07/2021
1Janus Kinase 1IBA
07/2021
1tofacitinibIBA
01/2021
1upadacitinibIBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Immunomodulating AgentsIBA
10/2020
1GSK2982772IBA
10/2020
1Protein Kinases (Protein Kinase)IBA
10/2020
1Omalizumab (Xolair)FDA Link
07/2020
1Triamcinolone (Aristocort)FDA Link
01/2020
1crisaboroleIBA
01/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2018
1TYK2 Kinase (Tyrosine Kinase 2)IBA
10/2018
1deucravacitinibIBA
10/2018

Therapy/Procedure

33Therapeutics
07/2022 - 09/2004
8Biological Therapy
01/2022 - 02/2007
4Phototherapy (Light Therapy)
07/2012 - 09/2004
2Aftercare (After-Treatment)
07/2020 - 01/2016